I think it's very good report considering the company which were on administration and now cash flow is looking good and will be more positive in coming months/years.
During this quarter the company sold a total of 11,228 WMT nickel concentrates @ 8.81% Ni and
received US$10,473,153 as preliminary proceeds.
see more projects and drilling in coming months. see below
NICKEL PROJECTS, TANZANIA
1.Songea JV (Albidon Limited 100%)
Preparation of drilling of selected targets is underway.
To date a total of 1,040 samples have been collected and submitted to ALS for assay.
2.IIagala Project (Albidon Limited 100%)
No work was conducted in the quarter.
3 NICKEL PROJECTS, BOTSWANA
Selebi-Phikwe Nickel-Copper Project
Albidon Limited 100%
No work was conducted in the quarter.
Albidon
CHIRUNDU URANIUM JOINT VENTURE, ZAMBIA
(Albidon 30%)
The Chirundu BFS continued in the September quarter. Mintek provided the final report on a
small programme of 2m high column leach tests to provide baseline metallurgical information.
The test work continued to demonstrate excellent leach characteristics for the Njame uranium
mineralisation, with recoveries of up to 95% achieved at less than 5kg/t acid consumption.
Environmental baseline monitoring programmes at the Njame and Gwabe uranium deposits and
their immediate environs continued during the quarter.
A small RC percussion drilling programme comprising 18 holes to test the Kabanana uranium
target was completed during the quarter. A best intersection of 4m @ 293 ppm U3O8 was
achieved in one hole.
- Forums
- ASX - By Stock
- ALB
- Ann: Quarterly Activities Report
ALB
albion resources limited
Add to My Watchlist
0.00%
!
5.7¢

Ann: Quarterly Activities Report , page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.520M |
Open | High | Low | Value | Volume |
5.7¢ | 5.7¢ | 5.4¢ | $21.73K | 384.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16805 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 90000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16805 | 0.054 |
1 | 49999 | 0.053 |
1 | 30000 | 0.051 |
2 | 145000 | 0.049 |
1 | 22222 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 90000 | 1 |
0.057 | 121825 | 2 |
0.059 | 50001 | 1 |
0.065 | 12500 | 1 |
0.070 | 200000 | 1 |
Last trade - 15.02pm 27/06/2025 (20 minute delay) ? |
Featured News
ALB (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online